Literature DB >> 24199658

NPHMC: an R-package for estimating sample size of proportional hazards mixture cure model.

Chao Cai1, Songfeng Wang, Wenbin Lu, Jiajia Zhang.   

Abstract

Due to advances in medical research, more and more diseases can be cured nowadays, which largely increases the need for an easy-to-use software in calculating sample size of clinical trials with cure fractions. Current available sample size software, such as PROC POWER in SAS, Survival Analysis module in PASS, powerSurvEpi package in R are all based on the standard proportional hazards (PH) model which is not appropriate to design a clinical trial with cure fractions. Instead of the standard PH model, the PH mixture cure model is an important tool in handling the survival data with possible cure fractions. However, there are no tools available that can help design a trial with cure fractions. Therefore, we develop an R package NPHMC to determine the sample size needed for such study design.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Power; Proportional hazards mixture cure model; R package; Sample size; Weighted log-rank test

Mesh:

Year:  2013        PMID: 24199658      PMCID: PMC3859312          DOI: 10.1016/j.cmpb.2013.10.001

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  6 in total

1.  A nonparametric mixture model for cure rate estimation.

Authors:  Y Peng; K B Dear
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Estimation in a Cox proportional hazards cure model.

Authors:  J P Sy; J M Taylor
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

3.  Sample-size formula for the proportional-hazards regression model.

Authors:  D A Schoenfeld
Journal:  Biometrics       Date:  1983-06       Impact factor: 2.571

4.  smcure: an R-package for estimating semiparametric mixture cure models.

Authors:  Chao Cai; Yubo Zou; Yingwei Peng; Jiajia Zhang
Journal:  Comput Methods Programs Biomed       Date:  2012-09-25       Impact factor: 5.428

5.  Sample size calculation for the proportional hazards cure model.

Authors:  Songfeng Wang; Jiajia Zhang; Wenbin Lu
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

6.  Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Authors:  J M Kirkwood; M H Strawderman; M S Ernstoff; T J Smith; E C Borden; R H Blum
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

  6 in total
  1 in total

1.  Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.

Authors:  Ujjwal M Mahajan; Elisabetta Goni; Enno Langhoff; Qi Li; Eithne Costello; William Greenhalf; Stephan Kruger; Steffen Ormanns; Christopher Halloran; Paula Ganeh; Manuela Marron; Felix Lämmerhirt; Yue Zhao; Georg Beyer; Frank-Ulrich Weiss; Matthias Sendler; Christiane J Bruns; Thomas Kohlmann; Thomas Kirchner; Jens Werner; Jan G D'Haese; Michael von Bergwelt-Baildon; Volker Heinemann; John P Neoptolemos; Markus W Büchler; Claus Belka; Stefan Boeck; Markus M Lerch; Julia Mayerle
Journal:  JNCI Cancer Spectr       Date:  2019-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.